Decongestants can raise blood pressure and trigger heart attacks or strokes in people with heart disease. Learn which ingredients to avoid, safer alternatives, and why even nasal sprays aren't always safe.
Decongestants like pseudoephedrine and phenylephrine can raise blood pressure and trigger heart problems in people with heart disease or hypertension. Learn why these common cold medicines are dangerous and what safer alternatives exist.
Modified-release formulations require specialized bioequivalence testing to ensure generics work as well as brand-name drugs. Learn how regulators assess release profiles, dissolution, and partial AUCs-and why some generics still fail patients.
Medicare can now negotiate prices for expensive prescription drugs. Starting in 2026, 10 top drugs will see discounts of 38% to 79%. Here’s how it works, who benefits, and what’s coming next.
Learn how to report counterfeit or tampered medications step by step. Whether you're a patient, pharmacist, or consumer, know where and how to report fake drugs to protect yourself and others.
The FDA extends expiration dates for critical drugs during shortages to keep life-saving medications available. Learn how it works, which drugs qualify, and how hospitals use this tool safely.
Learn how to spot misleading media reports about medication safety by checking study methods, understanding risk numbers, and verifying claims with trusted sources like FAERS and ISMP.
NTI drugs like warfarin and levothyroxine have a narrow safety margin. Switching between generic manufacturers can cause dangerous changes in blood levels. Here’s what you need to know to stay safe.
Patient satisfaction with generic medications isn't about science-it's about perception. Even when generics work the same, trust, communication, and past experience determine whether patients stick with them. Here's what really drives satisfaction-and how to fix it.
REMS programs are FDA-mandated safety systems for high-risk medications. Do they actually improve patient outcomes-or just add paperwork? Real data on cancer drugs, neurology treatments, and provider challenges.